Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Navamedic increases the consideration to SEK 0.60 in cash per warrant of series TO 1 in its unconditional offer to the warrant holders in Sensidose Aktiebolag

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or USA, or in any other jurisdiction where such offer pursuant to legislation, restrictions and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders and Warrant Holders not resident in Sweden who wish to accept the Offer, the Revised Offer, the Warrant Offer and the Revised Warrant Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders and

Valmet’s Interim Review January 1 – March 31, 2023: Orders received increased to EUR 1.55 billion and Comparable EBITA to EUR 133 million in the first quarter

Valmet’s Interim Review January 1 – March 31, 2023: Orders received increased to EUR 1.55 billion and Comparable EBITA to EUR 133 million in the first quarter Valmet Oyj’s stock exchange release on April 26, 2023 at 1:00 p.m. EEST Figures in brackets, unless otherwise stated, refer to the comparison period, i.e., the same period of the previous year. Net debt to EBITDA ratio, Comparable gross profit, and Comparable selling, general and administrative expenses (Comparable SG&A expenses) are new alternative performance measures. They enable users of the financial information to

Invitation to presentation of Eastnine's Interim report January-March 2023

Eastnine's interim report January-March 2023 will be published on Wednesday 3 May 2023, at 07.00 (CET). The same day at 10.00 (CET), we invite investors, analysts and media to a live presentation of the report.     Time for the webcast Wednesday 3 May 2023, at 10.00 (CET)   Click here  to see the webcast.   Please join the event a few minutes before the presentation begins. An investor presentation will be available at www.eastnine.com 15 minutes before the start of the webcast. A recording of the webcast will be available

Tradedoubler annual report 2022 published

Tradedoubler has as of today published the annual report 2022. The annual report is prepared in Swedish and translated into English. Both versions are available at Tradedoubler’s website, see the following link: https://www.tradedoubler.com/en/investors/financial-information-and-publications/     For further information, please contact: Matthias Stadelmeyer, CEO Tradedoubler Phone: +46 8 405 08 00 Email: ir@tradedoubler.com     About this information This information is information that Tradedoubler AB is obliged to make public pursuant to the Swedish

Removing Blind Spots Through the Power of Data

Interview with Sam Frida, Chief Strategy Officer at DomainCrawler  You’ve been working with DomainCrawler for three months now. What are the highlights of this cooperation so far? I came in with no expectations. Having met Alona Borzhemska (CCO at DomainCrawler - e.n.), I had some idea of the company’s growth stage which was the exciting part of why I was driven to join. It was at the recent ICANN in Cancun when I became impressed with the external validation received on the data’s accuracy. In fact, it had given me a different perspective on the power of data. There is a

Notice of annual general meeting in Cyxone AB

The English text is an unofficial translation. In case of any discrepancies between the Swedish language version of this document and the English translation, the Swedish language version shall prevail. The shareholders in Cyxone AB, Reg. No. 559020-5471 (“Cyxone”), are hereby invited to the annual general meeting on Tuesday 30 May 2023 at 10.00 CEST, at the company’s office, Hyllie Stationstorg 31 in Malmö, Sweden.Right to participate and notification Shareholders wishing to attend the annual general meeting must: · be registered in the company’s share register kept by Euroclear

Vattenfall's Annual General Meeting 2023

Vattenfall AB's Annual General Meeting (AGM) was held on Wednesday April 26. Among other things, the AGM decided on a dividend payout of SEK 4 billion to its owner, the Swedish State. Also, three new members were elected to the board and two members left the board.Vattenfall’s owner was represented at the AGM voting by  Gustaf Hygrell, Deputy Director at the Ministry of Finance. Annual General Meeting decisions: Adoption of balance sheet and income statement The AGM adopted the income and balance sheet for Vattenfall AB and the Vattenfall Group. Dividend The AGM decided on a

Bulletin from the Annual General Meeting of Swedish Logistic Property AB (publ)

The following resolutions were passed at the Annual General Meeting (the “AGM”) of Swedish Logistic Property (publ) (the “Company”) on 26 April 2023 in Malmö.Adoption of profit and loss account and balance sheet and discharge from liability The AGM resolved to adopt the profit and loss account and the balance sheet as well as the consolidated profit and loss account and the consolidated balance sheet for the financial year 2022. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2022. Allocation of results The AGM resolved, in

Interim Report of KONE Corporation for January–March 2023

KONE Corporation, stock exchange release, April 26, 2023 at 12.30 p.m. EEST Interim Report of KONE Corporation for January–March 2023 Good start to the year with sales growth and improved profitability  January–March 2023 · Orders received declined by 6.6% to EUR 2,263.1 (1–3/2022: 2,422.6) million. At comparable exchange rates, orders declined by 5.1%. · Sales grew by 4.7% to EUR 2,556.6 (2,441.9) million. At comparable exchange rates, sales grew by 5.9%. · Operating income (EBIT) was EUR 238.3 (171.1) million or 9.3% (7.0%) of sales. The adjusted EBIT was EUR 241.9 (

Alleima interim report Q1 2023

A solid start to the yearQ1 2023 highlights —    Organic order intake growth for the rolling 12-months period was 6%. Order intake in the quarter increased by 7% to SEK 6,416 million (5,996), with organic growth of -5%, due to high comparables resulting from major orders in the corresponding period of the preceding year. Organic order intake growth excluding major orders was 6%. —    Revenues increased by 27% to SEK 5,376 million (4,219), with organic growth of 12%, driven by growth in all three divisions. —    Adjusted operating profit (EBIT), amounted to SEK 567 million (384),

New data presented at ECCMID confirms that QuickMIC® outputs accurate AST results in record time

Gradientech today announces that the recently presented abstract “A multi-center evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections” concludes that its ultra-rapid and precise diagnostic system QuickMIC® can be used to determine antibiotic susceptibility and measure precise linear MIC (Minimum Inhibitory Concentration) values with very high accuracy, with time to result hours faster than competing AST (Antibiotic Susceptibility Testing) systems.The European multi-center study was presented at the 33rd European Congress of Clinical Microbiology &

Invitation to a presentation of ITAB’s Interim Report for the first quarter 2023

ITAB Shop Concept AB (publ) (“ITAB”) will publish its Interim Report for the first quarter 2023 on Wednesday, 10 May 2023 at 7:00 a.m. CEST. In conjunction with this, ITAB are pleased to issue this invitation to a webcast presentation in which President & CEO Andréas Elgaard and CFO Ulrika Bergmo Sköld will present the report and answer any subsequent questions.DATE: Wednesday, 10 May 2023 TIME: 10:30 a.m. CEST WEBCAST: To participate via webcast – please use the weblink below. Via the webcast you are able to ask questions in writing.https://ir.financialhearings.com/itab-shop-

LKAB releases Reports on the large increase of Mineral Resources

After exploration in 2022 LKAB now provides summary technical reports on the Mineral Resources and Mineral Reserves. ”The teams have again delivered very successful results for the year” says Ian Cope, Vice President Exploration at LKAB. Compared to 2021, the Mineral Resources have increased by 18 percent and Mineral Reserves have decreased by 6 percent. The Per Geijer deposit in Kiruna has for the first time reported a “rare earth element” Mineral Resource.The iron ore Mineral Reserves in Kiruna and Malmberget have decreased in line with mine production, also with some downgrading in the

Company announcement from SGL International A/S

26 April 2023Company announcement no. 67  SGL International A/S announces its intention to voluntarily redeem all its outstanding senior secured bonds with ISIN SE0013101219 and SE0015810759 and all its outstanding subordinated unsecured bonds with ISIN NO0012441007 SGL International A/S (the "Company") hereby announces its intention to exercise its right to make an early redemption of its up to EUR 315,000,000 senior secured floating rate bonds with ISIN SE0013101219, up to EUR 350,000,000 senior secured fixed rate bonds with ISIN SE0015810759 and EUR 41,150,000 subordinated

BeammWave granted contribution from Vinnova through a joint project

The project is coordinated by Advenica, and besides BeammWave also Ericsson, SAAB and Syntronic are project partners. The project has a total budget of 10.1 MSEK whereas the Vinnova grant, from the call “Avancerad och innovativ digitalisering 2023” is 4.9 MSEK and the BeammWave share of the grant has a total of 1.5 MSEK.The project title is “Secure systems with components from insecure manufacturing chains”. It has the objective to take BeammWave from a patented design and prototype to a validated production-ready product, and thus enable collaboration with commercial actors. "The

STOREBRAND ASA: Invitation to Result Presentation Q1 2023

In connection with the release of the results for Q1 2023, Storebrand invites to the following events: Wednesday 10 May 2023 07.30 CETRelease of stock exchange notification. Press release, quarterly report and analyst presentation will be available on www.storebrand.com/ir. 10.00 CETLive streamed investor and analyst conference in English. A webcast will be available for everyone to view on www.storebrand.com/ir, and will be available on demand afterwards. Analysts who would like to ask questions at the end of the presentation must register for and participate in the MS

Quartr Launches Its Long-Awaited Desktop Version

Finance software provider Quartr, most known for its Mobile App with over half a million users, launches its long-awaited desktop version. The Quartr Web App is a comprehensive research and productivity tool built entirely on first-party information from public companies. It is designed to meet the everyday needs of investors, analysts, journalists, and investor relations departments.The remarkable success of the Quartr Mobile App, having attracted over half a million users within two years of its launch, has sparked a strong demand for a desktop version. This resulted in the development of

(RETRANS) Scandinavian ChemoTech's subsidiary in the USA for Animal Care receives significant order from veterinary hospital chain

Retransmission of press release that was issued on April 25[th] 2023, 17.20. Vetiqure North America (VQ Animal Care INC) receives a significant order for TSE technology from Sage Veterinary Center (SVC) in San Fransisco, California, which amounts to approximately 28,000 USD.SVC is a group of veterinary hospitals consisting of five clinics offering unique facilities and the latest surgical and diagnostic technologies. SVC's surgeons perform a range of advanced procedures that include soft tissue, cancer, orthopedic and neurological surgeries. The surgeons collaborate with all departments

Immedica publishes Business Review and Annual & Sustainability report 2022

Stockholm, April 26 , 2023 - Immedica has today published its Business review and Annual & Sustainability report 2022. This is the first report for Immedica in this format. Immedica is a young  and still relatively small company, but our ambitions are nothing but high. “At Immedica, we believe we have an important role to fill in society in bringing new innovative treatments to patients with rare diseases for whom there are currently no viable treatment options.”comments Anders Edvell CEO. The integrated report is attached to his announcement. About Immedica Pharma

National Grid and Linxon breaks ground on a new substation in the heart of London

· National Grid and Linxon announced the start of construction on a new high voltage substation at Bengeworth Road, as part of the £1bn London Power Tunnels Project to rewire London · New substation will help power homes and businesses across London, balance voltage on the network and allow more future renewable electricity to connect to the gridA major milestone has been reached in the construction of a new 400kV electricity substation in Bengeworth Road, Lambeth with teams from National Grid and Linxon making a start on the construction of the substation. The new substation in the

Reminder: Invitation to the presentation of first quarter 2023 accounts, Thursday 4 May

SpareBank 1 SR-Bank's first quarter 2023 accounts will be released at 7:30 a.m. on Thursday 4 May, and we would like to invite you to the following presentations: 8:15 a.m. CET - Presentation in Norwegian, live and webcast Location: SpareBank 1 Markets, Olav V's gate 5, Oslo. The presentation will be held by CEO Benedicte Schilbred Fasmer and CFO Inge Reinertsen. It will also be available as a webcast on the Investor Relations pages at www.sr-bank.no/ir. Breakfast is served from 8:00 a.m. 1:30 p.m. CET - Digital presentation for analysts and investors in English CEO

Deal frequency in life science gives hope for recovery

The beginning of 2023 have seen big pharma open their wallets – at least compared to last year. The deal volume already exceeds that of 2022. Analysts believe this is the start of a surge of deals where pharmaceutical giants aim to secure their portfolios with next-generation blockbuster drugs.Read the full article at biostock.se : https://www.biostock.se/en/2023/04/deal-frequency-in-life-science-gives-hope-for-recovery/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top